Krutrim Launches Indias First Frontier Research AI Lab to Democratise AI Innovation; Commits Investment of $1.2 Billion by Next Year
Announces investment of $230 million (equity and debt) today Releases Krutrim-2 12B,-…
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated…